Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 8/20 | 0.49 |
| ▸ | CDC25A | P30304 | 6/20 | 0.49 |
| ▸ | S100A4 | P26447 | 5/20 | 0.49 |
| ▸ | MAP2K7 | O14733 | 4/20 | 0.49 |
| ▸ | AURKA | O14965 | 1/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | MITF | O75030 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 3/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1671378 | 0.84 | CDC25B (0.44) | CDC25BCDC25AS100A4MAP2K7AURKA | |
| SCHEMBL5822470 | 0.79 | CDC25B (0.50) | CDC25BCDC25AS100A4MAP2K7AURKA | |
| SCHEMBL12761943 | 0.76 | AURKA (0.48) | CDC25BCDC25AS100A4MAP2K7AURKA | |
| SCHEMBL10446607 | 0.74 | CDC25B (0.49) | CDC25BCDC25AS100A4MAP2K7AURKA | |
| SCHEMBL15520817 | 0.74 | CDC25B (0.36) | CDC25BCDC25AS100A4MAP2K7AURKA | |
| SCHEMBL22874151 | 0.74 | CDC25B (0.54) | CDC25BCDC25AS100A4MAP2K7AURKA | |
| SCHEMBL29941466 | 0.72 | CDC25B (0.68) | CDC25BCDC25AS100A4MAP2K7AURKA | |
| SCHEMBL571026 | 0.72 | CDC25B (0.68) | CDC25BCDC25AS100A4MAP2K7AURKA | |
| Water SCHEMBL8664586 | 0.70 | CDC25B (0.65) | CDC25BCDC25AS100A4MAP2K7AURKA | |
| SCHEMBL7915423 | 0.69 | CDC25B (0.48) | CDC25BCDC25AS100A4MAP2K7AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106132401-B | Compositions and methods for enhancing topical application of acidic benefit agents | 强生消费者公司 | 2020-06-09 | — | — | CN | disclosed |
| US-20090247472-A1 | TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS | FLUOFARMA (FR) | 2009-10-01 | — | — | US | disclosed |
| EP-2010481-A1 | TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS | Fluofarma (FR) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007125196-A1 | TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS | FLUOFARMA (FR) | 2007-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247472-A1 | TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS | CCNA1, MKI67, CCNT1 | CDC25B 90/4885CDC25A 14/4885S100A4 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.